Dual target inhibitors based on EGFR: Promising anticancer agents for the treatment of cancers (2017-)
出版年份 2021 全文链接
标题
Dual target inhibitors based on EGFR: Promising anticancer agents for the treatment of cancers (2017-)
作者
关键词
Anticancer, EGFR, Dual target inhibitors, Design, SARs
出版物
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 227, Issue -, Pages 113963
出版商
Elsevier BV
发表日期
2021-10-30
DOI
10.1016/j.ejmech.2021.113963
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Pyrazolo[3,4-d]pyrimidine-based dual EGFR T790M/HER2 inhibitors: Design, synthesis, structure–activity relationship and biological activity as potential antitumor and anticonvulsant agents
- (2021) Phoebe F. Lamie et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- FGFR-TKI resistance in cancer: current status and perspectives
- (2021) Sitong Yue et al. Journal of Hematology & Oncology
- The basic route of nuclear‐targeted transport of IGF‐1/IGF‐1R and potential biological functions in intestinal epithelial cells
- (2021) Ming Xiu et al. CELL PROLIFERATION
- Design, synthesis and biological evaluation of sulfamoylphenyl-quinazoline derivatives as potential EGFR/CAIX dual inhibitors
- (2021) Bin Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Diversity of insulin and IGF signaling in breast cancer: Implications for therapy
- (2021) Michael W. Lero et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- AKT Inhibitors: New Weapons in the Fight Against Breast Cancer?
- (2021) Federica Martorana et al. Frontiers in Pharmacology
- Design, synthesis and anticancer evaluation of new 4-anilinoquinoline-3-carbonitrile derivatives as dual EGFR/HER2 inhibitors and apoptosis inducers
- (2021) Min Zou et al. BIOORGANIC CHEMISTRY
- Design, synthesis and biological evaluation of 2,3-dihydroimidazo[2,1-b]thiazoles as dual EGFR and IGF1R inhibitors
- (2021) Pradip K. Gadekar et al. BIOORGANIC CHEMISTRY
- Aurora kinase inhibitors as potential anticancer agents: Recent advances
- (2021) Tathagata Pradhan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design and synthesis of a novel class EGFR/HER2 dual inhibitors containing tricyclic oxazine fused quinazolines scaffold
- (2020) Min Sun et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Tubulin Proteins in Cancer Resistance: A review
- (2020) Mohammad A. Kamal et al. CURRENT DRUG METABOLISM
- Recent Advances in Multi-target Drugs Targeting Protein Kinases and Histone Deacetylases in Cancer Therapy
- (2020) Yong Ling et al. CURRENT MEDICINAL CHEMISTRY
- Compound 15c, a Novel Dual Inhibitor of EGFRL858R/T790M and FGFR1, Efficiently Overcomes Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance of Non-Small-Cell Lung Cancers
- (2020) Gaozhi Chen et al. Frontiers in Pharmacology
- Potent dual EGFR/Her4 tyrosine kinase inhibitors containing novel (1,2-dithiolan-4-yl)acetamides
- (2020) Tarek S. Mansour et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Single and dual target inhibitors based on Bcl-2: Promising anti-tumor agents for cancer therapy
- (2020) Tingting Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells
- (2020) Abderrahim El Guerrab et al. Scientific Reports
- Recent advances in inhibitors of C-terminal SRC kinase
- (2020) Daniel P O’Malley Future Medicinal Chemistry
- The clinical efficacy of combinatorial therapy of EGFR-TKI and crizotinib in overcoming MET amplification-mediated resistance from prior EGFR-TKI therapy
- (2020) Yubo Wang et al. LUNG CANCER
- The combination of histone deacetylase inhibitors and radiotherapy: a promising novel approach for cancer treatment
- (2020) Ekta Shirbhate et al. Future Oncology
- Dual inhibitors of histone deacetylases and other cancer-related targets: A pharmacological perspective
- (2020) Yuan Gao et al. BIOCHEMICAL PHARMACOLOGY
- Discovery of CAPE derivatives as dual EGFR and CSK inhibitors with anticancer activity in a murine model of hepatocellular carcinoma
- (2020) Xiaoyu Liu et al. BIOORGANIC CHEMISTRY
- Recent progress on HDAC inhibitors with dual targeting capabilities for cancer treatment
- (2020) Xiaopeng Peng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2-d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors
- (2019) Romeo Romagnoli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel pyrazolo[3,4-d]pyrimidines: design, synthesis, anticancer activity, dual EGFR/ErbB2 receptor tyrosine kinases inhibitory activity, effects on cell cycle profile and caspase-3-mediated apoptosis
- (2019) Mai Maher et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer
- (2019) Lara Kujtan et al. Expert Review of Anticancer Therapy
- Strategies to overcome acquired resistance to EGFR TKI in the treatment of non-small cell lung cancer
- (2019) J. Gao et al. Clinical & Translational Oncology
- AKT as a Therapeutic Target for Cancer
- (2019) Mengqiu Song et al. CANCER RESEARCH
- FGFR1 Cooperates with EGFR in Lung Cancer Oncogenesis, and Their Combined Inhibition Shows Improved Efficacy
- (2019) Alvaro Quintanal-Villalonga et al. Journal of Thoracic Oncology
- Lead generation of 1,2-dithiolanes as exon 19 and exon 21 mutant EGFR tyrosine kinase inhibitors
- (2019) Tarek S. Mansour et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer
- (2019) Qiming Wang et al. Journal of Hematology & Oncology
- Design, Synthesis and Biological Evaluation of Novel Osimertinib-Based HDAC and EGFR Dual Inhibitors
- (2019) Hang Dong et al. MOLECULES
- The FGF metabolic axis
- (2019) Xiaokun Li Frontiers of Medicine
- Facts and New Hopes on Selective FGFR Inhibitors in Solid Tumors
- (2019) Francesco Facchinetti et al. CLINICAL CANCER RESEARCH
- Design, synthesis and biological evaluation of novel 4-anilinoquinazoline derivatives as hypoxia-selective EGFR and VEGFR-2 dual inhibitors
- (2019) Huiqiang Wei et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- 1,2,4-Oxadiazole derivatives targeting EGFR and c-Met degradation in TKI resistant NSCLC
- (2019) Eman M.E. Dokla et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Drug resistance of BRAF-mutant melanoma: Review of up-to-date mechanisms of action and promising targeted agents
- (2019) Alessandro Rossi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Design, synthesis and biological evaluation of benzoylacrylic acid shikonin ester derivatives as irreversible dual inhibitors of tubulin and EGFR
- (2019) Wen-Xue Sun et al. BIOORGANIC & MEDICINAL CHEMISTRY
- New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies
- (2019) Nehad A. El-Sayed et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- HER4 promotes cell survival and chemoresistance in osteosarcoma via interaction with NDRG1
- (2018) Hongsheng Wang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Molecular dynamics guided development of indole based dual inhibitors of EGFR (T790M) and c-MET
- (2018) Pankaj Kumar Singh et al. BIOORGANIC CHEMISTRY
- Dual EGFR/HER2 inhibitors and apoptosis inducers: New benzo[ g ]quinazoline derivatives bearing benzenesulfonamide as anticancer and radiosensitizers
- (2018) Mostafa M. Ghorab et al. BIOORGANIC CHEMISTRY
- Interactions between EGFR and PD-1/PD-L1 pathway: Implications for treatment of NSCLC
- (2018) Xue Li et al. CANCER LETTERS
- Recent advances in trimethoxyphenyl (TMP) based tubulin inhibitors targeting the colchicine binding site
- (2018) Ling Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and anticancer evaluation of novel spirobenzo[ h ]chromene and spirochromane derivatives with dual EGFR and B-RAF inhibitory activities
- (2018) Shaimaa A. Abdelatef et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Identification of novel N 1 -(2-aryl-1, 3-thiazolidin-4-one)- N 3 -aryl ureas showing potent multi-tyrosine kinase inhibitory activities
- (2018) Baohui Qi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis of a novel 4-O-methylsaucerneol analogue LXY7824 as potent HIF-1 inhibitor and anti-cancer agent
- (2018) Xiao-Yu Liu et al. JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH
- Expressions and clinical significance of HER4 and CD44 in sinonasal mucosal malignant melanoma
- (2018) Wenjia Zhu et al. MELANOMA RESEARCH
- C-terminal Src kinase (Csk) regulates the tricellular junction protein Gliotactin independent of Src
- (2018) G. D. N. Gayathri Samarasekera et al. MOLECULAR BIOLOGY OF THE CELL
- Hypoxia Promotes Resistance to EGFR Inhibition in NSCLC Cells via the Histone Demethylases, LSD1 and PLU-1
- (2018) Yuhong Lu et al. MOLECULAR CANCER RESEARCH
- Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
- (2018) Amila Suraweera et al. Frontiers in Oncology
- Discovery of new quinazoline derivatives as irreversible dual EGFR/HER2 inhibitors and their anticancer activities – Part 1
- (2018) Debasis Das et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Cyclooxygenase-2 in cancer: A review
- (2018) Nasser Hashemi Goradel et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Mechanism of Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and a Potential Treatment Strategy
- (2018) Tatsuya Nagano et al. Cells
- Design, synthesis, in silico pharmacokinetics prediction and biological evaluation of 1,4-dihydroindeno[1,2-c]pyrazole chalcone as EGFR /Akt pathway inhibitors
- (2018) Irfan Khan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structure-based design and synthesis of 2,4-diaminopyrimidines as EGFR L858R/T790M selective inhibitors for NSCLC
- (2017) Lingfeng Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a potent dual ALK and EGFR T790M inhibitor
- (2017) Jaebong Jang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design and discovery of 4-anilinoquinazoline-urea derivatives as dual TK inhibitors of EGFR and VEGFR-2
- (2017) Hai-Qi Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Recent updates on third generation EGFR inhibitors and emergence of fourth generation EGFR inhibitors to combat C797S resistance
- (2017) Harun Patel et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Benzo[g]quinazolin benzenesulfonamide derivatives as dual EGFR/HER2 inhibitors
- (2017) Mansour S. Alsaid et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and evaluation of azaacridine derivatives as dual-target EGFR and Src kinase inhibitors for antitumor treatment
- (2017) Zhishan Cui et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of N -(5-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-4-methoxy-2-(4-methyl-1,4-diazepan-1-yl)phenyl)acrylamide (CHMFL-ALK/EGFR-050) as a potent ALK/EGFR dual kinase inhibitor capable of overcoming a variety of ALK/EGFR associated drug resistant mutants in NSCLC
- (2017) Yongfei Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A brief perspective of drug resistance toward EGFR inhibitors: the crystal structures of EGFRs and their variants
- (2017) Haixing Guan et al. Future Medicinal Chemistry
- Clinical significance of overexpression of NRG1 and its receptors, HER3 and HER4, in gastric cancer patients
- (2017) Sumi Yun et al. Gastric Cancer
- Early emergence of negative regulation of the tyrosine kinase Src by the C-terminal Src kinase
- (2017) Barbara Taskinen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Design, synthesis and biological activity of N4-phenylsubstituted-7H-pyrrolo[2,3-d]pyrimidin-4-amines as dual inhibitors of aurora kinase A and epidermal growth factor receptor kinase
- (2017) Sonali Kurup et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and PDGFR-β related to anticancer drug resistance
- (2017) Tim Fischer et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- First Bispecific Inhibitors of the Epidermal Growth Factor Receptor Kinase and the NF-κB Activity As Novel Anticancer Agents
- (2017) Mostafa M. Hamed et al. JOURNAL OF MEDICINAL CHEMISTRY
- Caffeic acid phenethyl ester upregulates N-myc downstream regulated gene 1 via ERK pathway to inhibit human oral cancer cell growth in vitro and in vivo
- (2017) Li-Chuan Chung et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Design and Discovery of Quinazoline- and Thiourea-Containing Sorafenib Analogs as EGFR and VEGFR-2 Dual TK Inhibitors
- (2017) Shaofeng Sun et al. MOLECULES
- Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects
- (2017) Mohamed Alswah et al. MOLECULES
- A Phase I Dose‐Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid Tumors
- (2017) Stephen Leong et al. ONCOLOGIST
- Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer
- (2017) Ken Uchibori et al. Nature Communications
- Synthesis of 4-Anilinoquinazoline-Derivative Dual Kinase Inhibitors Targeting EGFR and VEGFR-2
- (2017) Keuk Chan Bang et al. BULLETIN OF THE KOREAN CHEMICAL SOCIETY
- Light-Activated Hypoxia-Responsive Nanocarriers for Enhanced Anticancer Therapy
- (2016) Chenggen Qian et al. ADVANCED MATERIALS
- Small Molecule T315 Promotes Casitas B-Lineage Lymphoma–Dependent Degradation of Epidermal Growth Factor Receptor via Y1045 Autophosphorylation
- (2016) Kuo-Yen Huang et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site
- (2016) Xiaoxin Wu et al. Anti-Cancer Agents in Medicinal Chemistry
- Design, synthesis and evaluation of acridine derivatives as multi-target Src and MEK kinase inhibitors for anti-tumor treatment
- (2016) Zhishan Cui et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer
- (2016) Jennifer L. Hsu et al. CANCER AND METASTASIS REVIEWS
- The platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) are major players in oncogenesis, drug resistance, and attractive oncologic targets in cancer
- (2016) Ying Wang et al. GROWTH FACTORS
- FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review)
- (2016) MASARU KATOH INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Development of Autotaxin Inhibitors: An Overview of the Patent and Primary Literature
- (2016) Diana Castagna et al. JOURNAL OF MEDICINAL CHEMISTRY
- Challenges and Perspectives on the Development of Small-Molecule EGFR Inhibitors against T790M-Mediated Resistance in Non-Small-Cell Lung Cancer
- (2016) Zhendong Song et al. JOURNAL OF MEDICINAL CHEMISTRY
- Overcoming EGFR Bypass Signal-Induced Acquired Resistance to ALK Tyrosine Kinase Inhibitors in ALK-Translocated Lung Cancer
- (2016) Masayoshi Miyawaki et al. MOLECULAR CANCER RESEARCH
- Design and Synthesis of Vandetanib Derivatives Containing Nitroimidazole Groups as Tyrosine Kinase Inhibitors in Normoxia and Hypoxia
- (2016) Huiqiang Wei et al. MOLECULES
- Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort
- (2016) M Apicella et al. ONCOGENE
- 1,3,4-Oxadiazole derivatives as potential antitumor agents: discovery, optimization and biological activity valuation
- (2016) Yin Luo et al. MedChemComm
- TC-N19, a novel dual inhibitor of EGFR and cMET, efficiently overcomes EGFR-TKI resistance in non-small-cell lung cancer cells
- (2016) D-W Wu et al. Cell Death & Disease
- Cyclooxygenase-2: A Role in Cancer Stem Cell Survival and Repopulation of Cancer Cells during Therapy
- (2016) Lisa Y. Pang et al. Stem Cells International
- Discovery of a novel class anti-proliferative agents and potential inhibitors of EGFR tyrosine kinases based on 4-anilinotetrahydropyrido[4,3-d]pyrimidine scaffold: Design, synthesis and biological evaluations
- (2015) Yong Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Activation of EGFR Bypass Signaling by TGF Overexpression Induces Acquired Resistance to Alectinib in ALK-Translocated Lung Cancer Cells
- (2015) T. Tani et al. MOLECULAR CANCER THERAPEUTICS
- Aurora Kinase Inhibitors in Oncology Clinical Trials: Current State of the Progress
- (2015) Gerald S. Falchook et al. SEMINARS IN ONCOLOGY
- The importance of Src signaling in sarcoma
- (2015) QUANCHI CHEN et al. Oncology Letters
- Spirochromone-chalcone conjugates as antitubercular agents: synthesis, bio evaluation and molecular modeling studies
- (2015) M. Mujahid et al. RSC Advances
- Synthesis, molecular modeling, and biological evaluation of quinazoline derivatives containing the 1,3,4-oxadiazole scaffold as novel inhibitors of VEGFR2
- (2015) Fang Qiao et al. RSC Advances
- NF-κB-Activating Complex Engaged in Response to EGFR Oncogene Inhibition Drives Tumor Cell Survival and Residual Disease in Lung Cancer
- (2015) Collin M. Blakely et al. Cell Reports
- Design, Synthesis, and Biological Evaluation of Hydrazone Incorporated 1,2,4-Triazines as Anticonvulsant Agents
- (2014) Mohammed Amir et al. ARCHIV DER PHARMAZIE
- Chalcone based azacarboline analogues as novel antitubulin agents: Design, synthesis, biological evaluation and molecular modelling studies
- (2014) Sahil Sharma et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- LPA receptor signaling: pharmacology, physiology, and pathophysiology
- (2014) Yun C. Yung et al. JOURNAL OF LIPID RESEARCH
- Synthesis, Structure–Activity Relationship Studies, and Antibacterial Evaluation of 4-Chromanones and Chalcones, as Well as Olympicin A and Derivatives
- (2014) Li Feng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Polypharmacology: Challenges and Opportunities in Drug Discovery
- (2014) Andrew Anighoro et al. JOURNAL OF MEDICINAL CHEMISTRY
- Anticonvulsant activity of 1,2,4-triazine derivatives with pyridyl side chain: synthesis, biological, and computational study
- (2014) Hamid Irannejad et al. MEDICINAL CHEMISTRY RESEARCH
- A Synthetic Manassantin A Derivative Inhibits Hypoxia-Inducible Factor 1 and Tumor Growth
- (2014) Liwei Lang et al. PLoS One
- Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers
- (2013) Kai Hung Tiong et al. APOPTOSIS
- Does a Single Nucleotide Polymorphism in the FGFR Explain the Connection between Diabetes and Cancer?
- (2013) Emily J. Gallagher et al. Cell Metabolism
- Characteristics of Lung Cancers Harboring NRAS Mutations
- (2013) K. Ohashi et al. CLINICAL CANCER RESEARCH
- Novel 2-chloro-4-anilino-quinazoline derivatives as EGFR and VEGFR-2 dual inhibitors
- (2013) Maria Letícia de Castro Barbosa et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Autotaxin inhibitors: a patent review
- (2013) Efrosini Barbayianni et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3
- (2013) Ethan V. Abel et al. JOURNAL OF CLINICAL INVESTIGATION
- Bypass Mechanisms of Resistance to Receptor Tyrosine Kinase Inhibition in Lung Cancer
- (2013) M. J. Niederst et al. Science Signaling
- Multifarious functions of PDGFs and PDGFRs in tumor growth and metastasis
- (2013) Yihai Cao TRENDS IN MOLECULAR MEDICINE
- Platelet-derived growth factors and their receptors: Structural and functional perspectives
- (2012) Po-Han Chen et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Design, synthesis and biological activities of sorafenib derivatives as antitumor agents
- (2012) Jianwen Yao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Caffeic Acid Phenethyl Ester Suppresses the Proliferation of Human Prostate Cancer Cells through Inhibition of p70S6K and Akt Signaling Networks
- (2012) C.-P. Chuu et al. Cancer Prevention Research
- Oncogenic Mutations Counteract Intrinsic Disorder in the EGFR Kinase and Promote Receptor Dimerization
- (2012) Yibing Shan et al. CELL
- Designed Multiple Ligands: Basic Research vs Clinical Outcomes
- (2012) L. Costantino et al. CURRENT MEDICINAL CHEMISTRY
- Exploring Pharmacological Significance of Chalcone Scaffold: A Review
- (2012) N. K. Sahu et al. CURRENT MEDICINAL CHEMISTRY
- Molecular Mechanisms and Modulation of Key Pathways Underlying the Synergistic Interaction of Sorafenib with Erlotinib in Non-Small-Cell-Lung Cancer (NSCLC) Cells
- (2012) E. Giovannetti et al. CURRENT PHARMACEUTICAL DESIGN
- Regulation of the Src Family Kinases by Csk
- (2012) Masato Okada International Journal of Biological Sciences
- Targeted therapy for triple-negative breast cancer: Where are we?
- (2012) Michael J. Duffy et al. INTERNATIONAL JOURNAL OF CANCER
- Vascular Endothelial Growth Factor (VEGF) Receptors: Drugs and New Inhibitors
- (2012) Francesca Musumeci et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and antitumor studies of novel benzopyrano-1,2,3-selenadiazole and spiro[benzopyrano]-1,3,4-thiadiazoline derivatives
- (2012) S. I. El-Desoky et al. MEDICINAL CHEMISTRY RESEARCH
- Combined Therapy with Mutant-Selective EGFR Inhibitor and Met Kinase Inhibitor for Overcoming Erlotinib Resistance in EGFR-Mutant Lung Cancer
- (2012) T. Nakagawa et al. MOLECULAR CANCER THERAPEUTICS
- An FGFR antibody with long-lasting effects
- (2012) Charlotte Harrison NATURE REVIEWS DRUG DISCOVERY
- EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib
- (2012) Ryan B. Corcoran et al. Cancer Discovery
- EGFR Mutations and Lung Cancer
- (2011) Gilda da Cunha Santos et al. Annual Review of Pathology-Mechanisms of Disease
- Synthesis, biological evaluation, and molecular modeling of cinnamic acyl sulfonamide derivatives as novel antitubulin agents
- (2011) Yin Luo et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer
- (2011) Jing Wu et al. CANCER LETTERS
- A Novel ALK Secondary Mutation and EGFR Signaling Cause Resistance to ALK Kinase Inhibitors
- (2011) T. Sasaki et al. CANCER RESEARCH
- Hypoxia Predicts Aggressive Growth and Spontaneous Metastasis Formation from Orthotopically Grown Primary Xenografts of Human Pancreatic Cancer
- (2011) Q. Chang et al. CANCER RESEARCH
- Identification and Characterization of a Novel Integrin-Linked Kinase Inhibitor
- (2011) Su-Lin Lee et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and evaluation of novel stearoyl-CoA desaturase 1 inhibitors: 1′-{6-[5-(pyridin-3-ylmethyl)-1,3,4-oxadiazol-2-yl]pyridazin-3-yl}-3,4-dihydrospiro[chromene-2,4′-piperidine] analogs
- (2010) Yoshikazu Uto et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- High expression of AURKA and AURKB is associated with unfavorable cytogenetic abnormalities and high white blood cell count in patients with acute myeloid leukemia
- (2010) Antonio R. Lucena-Araujo et al. LEUKEMIA RESEARCH
- Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements
- (2010) Shivanni Kummar et al. NATURE REVIEWS DRUG DISCOVERY
- [4-(6,7-Disubstituted quinazolin-4-ylamino)phenyl] carbamic acid esters: a novel series of dual EGFR/VEGFR-2 tyrosine kinase inhibitors
- (2010) Antonio Garofalo et al. MedChemComm
- Targeting epigenetic networks with polypharmacology: a new avenue to tackle cancer
- (2010) Gianluigi Franci et al. Epigenomics
- A boronic acid chalcone analog of combretastatin A-4 as a potent anti-proliferation agent
- (2009) Yali Kong et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of 4-anilino-N-methylthieno[3,2-d]pyrimidines and 4-anilino-N-methylthieno[2,3-d]pyrimidines as potent apoptosis inducers
- (2009) William Kemnitzer et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Pharmacokinetics of caffeic acid phenethyl ester and its catechol-ring fluorinated derivative following intravenous administration to rats
- (2009) Xinyu Wang et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Combined Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor (EGFR) Blockade Inhibits Tumor Growth in Xenograft Models of EGFR Inhibitor Resistance
- (2009) G. N. Naumov et al. CLINICAL CANCER RESEARCH
- Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth
- (2009) Y H Zhao et al. ONCOGENE
- Synthesis and Ribonucleotide reductase inhibitory activity of thiosemicarbazones
- (2008) Kesavan Krishnan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Role of platelet-derived growth factors in physiology and medicine
- (2008) J. Andrae et al. GENES & DEVELOPMENT
- Antimitotic and Antiproliferative Activities of Chalcones: Forward Structure–Activity Relationship
- (2008) Ahcène Boumendjel et al. JOURNAL OF MEDICINAL CHEMISTRY
- Prolactin and ErbB4/HER4 Signaling Interact via Janus Kinase 2 to Induce Mammary Epithelial Cell Gene Expression Differentiation
- (2008) Rebecca S. Muraoka-Cook et al. MOLECULAR ENDOCRINOLOGY
- EGFR Tyrosine Kinase Inhibitors in Lung Cancer: An Evolving Story
- (2007) Lecia V. Sequist et al. Annual Review of Medicine
- Insulin-Like Signaling, Nutrient Homeostasis, and Life Span
- (2007) Akiko Taguchi et al. Annual Review of Physiology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started